Publications by the researcher in collaboration with Enrique Lerma Puertas (19)

2017

  1. CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma

    Virchows Archiv, Vol. 470, Núm. 1, pp. 81-90

2016

  1. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs

    Experimental and Molecular Pathology, Vol. 100, Núm. 3, pp. 460-468

2015

  1. FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma

    Breast Cancer Research and Treatment, Vol. 153, Núm. 2, pp. 465-474

  2. Osteopontin regulates VEGFA and ICAM-1 mRNA expression in breast carcinoma

    American Journal of Clinical Pathology

2014

  1. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence

    Human Pathology

  2. Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma

    British Journal of Cancer, Vol. 111, Núm. 4, pp. 689-695

2012

  1. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas

    Journal of Cancer, Vol. 3, Núm. 1, pp. 175-183

  2. Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas

    Human Pathology, Vol. 43, Núm. 11, pp. 1902-1909

  3. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

    British Journal of Cancer, Vol. 106, Núm. 8, pp. 1367-1373

2011

  1. Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma

    Modern Pathology, Vol. 24, Núm. 2, pp. 201-208

  2. Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas

    Human Pathology, Vol. 42, Núm. 11, pp. 1581-1588

  3. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: A cooperative effort?

    Human Pathology, Vol. 42, Núm. 1, pp. 103-110

2009

  1. Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

    Breast Cancer Research and Treatment, Vol. 117, Núm. 2, pp. 433-441

2008

  1. Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

    Virchows Archiv, Vol. 453, Núm. 2, pp. 133-139

  2. Reply to Rakha, Ellis and Reis-Filho

    Modern Pathology

2007

  1. Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)

    Modern Pathology, Vol. 20, Núm. 11, pp. 1200-1207

2001

  1. Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

    Breast, Vol. 10, Núm. 1, pp. 67-77

1997

  1. Prognostic value of S-Phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis

    Modern Pathology, Vol. 10, Núm. 3, pp. 216-222

1994

  1. Detection of steroid receptors in breast cancer: Relationship between EIA and IHC methods

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 54, Núm. 8, pp. 591-594